Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
07:00am, Tuesday, 08'th Nov 2022 Benzinga
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.
Digital World Acquisition Corp. (NAS
Strength Seen in Veru Inc. (VERU): Can Its 39.5% Jump Turn into More Strength?
04:31am, Tuesday, 08'th Nov 2022
Veru Inc. (VERU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
Dow Surges 400 Points; Crude Oil Down 1%
07:20pm, Monday, 07'th Nov 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
The Dow traded up 1.24% to 32,804.26 while the NASDAQ rose 0.67% to 10,545.27. The S&P 500
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
05:46pm, Monday, 07'th Nov 2022 Benzinga
Gainers
Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Veru Inc. (NASDAQ: VERU) shares jumped 47% to $15.22 following publication of briefing documents ahead of the Nov.
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
05:14pm, Monday, 07'th Nov 2022 Benzinga
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
The Dow traded up 0.68% to 32,621.97 while the NASDAQ rose 0.14% to 10,490.21. The S&P 500
Why Veru Stock Is Skyrocketing Today
04:47pm, Monday, 07'th Nov 2022 The Motley Fool
Investors are reacting positively to an FDA briefing document.
US Stocks Mixed; Dow Rises Over 50 Points
03:10pm, Monday, 07'th Nov 2022 Benzinga
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.
Following the market opening Monday, the Dow traded up 0.18% to 32,461.54 while the NASDAQ fell 0.25% to 10,
VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug
02:30pm, Monday, 07'th Nov 2022
Pharmaceutical firm Veru (NASDAQ: VERU ) kicked off the first complete week of November with a bang as it delivered overall positive results regarding its Covid-19 therapeutic sabizabulin. Targeting t
Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid
01:44pm, Monday, 07'th Nov 2022
Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment. The post Medical Leader Veru Catapults As FDA Preps To Dis
Why Veru Stock Is Skyrocketing Today
11:47am, Monday, 07'th Nov 2022
Investors are reacting positively to an FDA briefing document.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
10:20am, Wednesday, 26'th Oct 2022 Zacks Investment Research
Sector ETF report for PTH
Veru Announces Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022
12:30pm, Monday, 24'th Oct 2022 GlobeNewswire Inc.
MIAMI, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncolo
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
12:04pm, Tuesday, 18'th Oct 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."
Benzinga data shows analysts disagre
Veru to Present Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022
12:30pm, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncolo
MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology
